However, for coronary heart disease the difference is of borderline significance and confidence intervals for other outcome events are very wide - so we cannot entirely exclude the possibility of a causal effect of blinding.
← all excerpts
Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial.
1
—
—